Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
112.69
+0.59 (+0.53%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
May 01, 2024
Investors should look for opportunities to buy these leading healthcare companies, each of which posted strong Q1 results.
Via
InvestorPlace
7 Defensive Stocks Built to Withstand the Market’s Worst Storms
April 30, 2024
With the market operating under a worrisome backdrop, investors may want to target certain defensive stocks to buy.
Via
InvestorPlace
2 Beaten-Down Dividend Stocks to Buy and Hold Forever
April 28, 2024
These companies aren't in danger of becoming has-beens.
Via
The Motley Fool
Better Dividend Stock: AbbVie or Johnson & Johnson?
April 28, 2024
One thing is for sure: Dividend seekers can't go wrong with either.
Via
The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
April 27, 2024
You'll get dividends and more with these great stocks.
Via
The Motley Fool
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
April 25, 2024
Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions.
Via
Talk Markets
Behind the Scenes of Abbott Laboratories's Latest Options Trends
April 18, 2024
Via
Benzinga
Abbott Laboratories Dividend Stock Analysis
April 12, 2024
Abbott Laboratories discovers, develops, manufactures, and sells healthcare products. Its products include branded generic pharmaceuticals manufactured internationally, marketed, and sold outside the...
Via
Talk Markets
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
April 23, 2024
It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay.
Via
InvestorPlace
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
April 22, 2024
These dividend stocks have proved time and again why they're the cream of the crop and will rise to the top once more.
Via
InvestorPlace
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review
April 19, 2024
The Nasdaq and S&P 500 tumbled below their 50-day lines.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?
April 17, 2024
A sentiment of risk aversion looms over the markets during Wednesday’s trading session, triggering midday losses across the board in stocks and cryptocurrencies and prompting a flight towards bonds, as...
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
Abbott Laboratories Unusual Options Activity
April 11, 2024
Via
Benzinga
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
April 17, 2024
ABT earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024
April 17, 2024
ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Abbott Beats Q1 Expectations With $10 Billion In Sales, $0.98 EPS
April 17, 2024
Abbott has reported a strong start to the year with sales reaching $10.0 billion in Q1, driven by a 10.8 percent increase in organic sales growth.
Via
Talk Markets
Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings
April 17, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report
April 17, 2024
Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but shares fell.
Via
Investor's Business Daily
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance
April 17, 2024
Abbott Laboratories surpasses expectations with Q1 sales hitting $9.96B, a 10.8% rise driven by robust performance in Medical Devices, Established Pharmaceuticals, Nutrition, and Diagnostics. CEO...
Via
Benzinga
Wall Street Poised To Rebound From Slump As Earnings Optimism Grows: Analyst Eyes This S&P 500 Level As Attractive Entry Point
April 17, 2024
U.S. stocks are priming for a firmer start on Wednesday, potentially striving to inflect higher from the weakness seen so far in April. As some bullish market watchers pointed out there could be an...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For April 17, 2024
April 17, 2024
Companies Reporting Before The Bell • ASML Holding (NASDAQ:ASML) is projected to report quarterly earnings at $3.43 per share on revenue of $6.13 billion.
Via
Benzinga
Investor Optimism Decreases; Dow Ends 6-Session Losing Streak
April 17, 2024
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index remaining in the "Fear" zone on Tuesday. U.S. stocks closed mixed on Tuesday amid increased...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
April 17, 2024
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
April 16, 2024
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28.
Via
Talk Markets
3 Buy Rated Stocks To Consider As Earnings Approach
April 13, 2024
With the Q1 earnings season underway, there will be a microscope on companies that can continue to show improvements in their outlook amid an uptick in inflation.
Via
Talk Markets
Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer
April 12, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc.
Via
Benzinga
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
April 12, 2024
Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end?
Via
Investor's Business Daily
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
April 11, 2024
These companies provide stability, reliability, and passive income.
Via
The Motley Fool
7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape
April 10, 2024
Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods.
Via
InvestorPlace
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
April 09, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Abbott Laboratories (NYSE: ABT) over
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.